Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-04-02 09:01 am Sale | 13D | NEON THERAPEUTICS INC NTGN | Access Industries Holdings LLC | 2,153,803 7.46% | -400,000 (-15.66%) | View |
| 2020-03-31 08:22 am Unchanged | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 40.1% | 0 (Unchanged) | View |
| 2020-03-27 2:29 pm Sale | 13D | NEON THERAPEUTICS INC NTGN | Access Industries Holdings LLC | 2,553,803 8.85% | -544,110 (-17.56%) | View |
| 2020-03-12 1:23 pm Purchase | 13G | PASSAGE BIO INC PASG | Access Industries Holdings LLC | 2,616,630 5.9% | 2,616,630 (New Position) | View |
| 2020-02-14 1:43 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Access Industries Holdings LLC | 3,028,742 9.9% | 1,370,794 (+82.68%) | View |
| 2020-01-13 5:27 pm Unchanged | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 40.1% | 0 (Unchanged) | View |
| 2019-12-31 5:10 pm Unchanged | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 40.1% | 0 (Unchanged) | View |
| 2019-10-09 5:27 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Access Industries Holdings LLC | 1,657,948 6.1% | 1,657,948 (New Position) | View |